Potential of E-Cigarettes to Improve Public Health: Expert Opinion

Sep.19.2022
Potential of E-Cigarettes to Improve Public Health: Expert Opinion
Tikki Pangestu believes e-cigarettes have potential to improve public health, citing data from independent UK studies.

Tikki Pangestu, a former director of policy research and cooperation at the World Health Organization, discussed the potential of e-cigarettes to improve public health. Professor Pangestu made a positive statement during an online discussion titled "Reducing Smoking Harm: Is it Possible to Reduce Tobacco Harm?


Professor Tikki Pang is currently a visiting professor at the Yong Loo Lin School of Medicine at the National University of Singapore. Prior to serving as Director of the World Health Organization, he was a professor at the Lee Kuan Yew School of Public Policy and a biomedical professor at the University of Malaya.


In his academic career spanning 30 years, Professor Peng has published over 250 scientific articles and 12 books covering topics such as epidemiology, pathogenesis, laboratory diagnosis, prevention of infectious diseases, biosafety, and dual-use research. He is recognized as an expert in public health both domestically and internationally.


According to Tikki Pang, there are still nearly 70 million smokers in his country, which has resulted in economic costs for the nation and significant socioeconomic burden for individuals.


He said, "From a public health and socio-economic perspective, this issue requires a strategic intervention and policy to reduce smoking rates in Indonesia.


Compared to products such as nicotine replacement therapy, interventions using products that promote harm reduction concepts are more effective for those who wish to quit smoking. This is a key strategy in addressing this highly complex issue. The products that result from technological advances and innovation have enormous potential.


Professor Peng cites facts and data from independent research in the UK to urge Indonesian lawmakers to accept electronic cigarettes, snus, and heated tobacco products.


The road to a healthier nation depends on the government ensuring that adult smokers have easy access to lesser harmful new nicotine products and that the information provided is accurate and truthful.


British cancer expert Peter Harper agrees with this. He commented, "You smoke to satisfy your need for nicotine, but you die from smoking. Quitting smoking immediately is one solution. However, current strategies are not effective. Innovative products provide solutions for those struggling to quit, while reducing the overall impact on well-being.


Statement:


This article is compiled from third-party information and is intended solely for communication and learning within the industry.


This article does not represent the views of 2FIRSTS, and 2FIRSTS cannot confirm the authenticity or accuracy of the content. The translation of this article is only intended for industry exchange and research purposes.


Due to limitations in our translation abilities, the translated article may not perfectly reflect the original text. Please refer to the original article for accuracy.


2FIRSTS holds the same views and positions as the Chinese government regarding any domestic, Hong Kong, Macau, Taiwan, and foreign-related statements and stances.


The copyright of the compiled information belongs to the original media and author. If there is any infringement, please contact us for deletion.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Altria Reports Q1 2026 Net Revenues of $5.43 Billion and 7.3% Growth in Adjusted Diluted EPS
Altria Reports Q1 2026 Net Revenues of $5.43 Billion and 7.3% Growth in Adjusted Diluted EPS
Altria Group reported its first-quarter 2026 results on April 30. Net revenues were $5.43 billion, up 3.2% year on year, while revenues net of excise taxes were $4.76 billion, up 5.3%. Reported diluted EPS was $1.30, up more than 100%, and adjusted diluted EPS was $1.32, up 7.3%.
May.06 by 2FIRSTS.ai
South Korea Expands Tobacco Harmful Components Testing System to Cover Synthetic Nicotine Liquid Vapes
South Korea Expands Tobacco Harmful Components Testing System to Cover Synthetic Nicotine Liquid Vapes
South Korea’s Ministry of Food and Drug Safety said on April 17 that it has additionally designated the International Characterization Research Institute as a tobacco harmful components testing body under the Act on the Management of Tobacco Harmfulness. The institute has research experience in analyzing harmful components in liquid e-cigarettes and has obtained recognition for tobacco-sector ISO 17025 requirements.
Apr.17 by 2FIRSTS.ai
Product | 20ml E-liquid, Dual Modes with Up to 60,000 Puffs, Uwell Launches VALAYA AMP 60K Vape in the U.S.
Product | 20ml E-liquid, Dual Modes with Up to 60,000 Puffs, Uwell Launches VALAYA AMP 60K Vape in the U.S.
Uwell has recently launched its new disposable vape, the VALAYA AMP 60K, on its official website. The device features 20ml of pre-filled e-liquid and is rated for up to approximately 60,000 puffs. It is equipped with a 950mAh rechargeable battery and a 0.6Ω dual mesh coil. The product is now available through select online channels in the United States, with a listed price of $19.99.
Apr.09 by 2FIRSTS.ai
Glas Says FDA Scientific Review Backed Several Flavored Products Before Senior Leaders Blocked Them
Glas Says FDA Scientific Review Backed Several Flavored Products Before Senior Leaders Blocked Them
Glas says newly released internal FDA records show agency scientific reviewers supported authorization for several flavored G2 products before senior leadership halted them. According to documents obtained through a Freedom of Information Act request, FDA’s Office of Science first recommended marketing authorization for all eight products in December 2025 and later supported six of them in February 2026. FDA ultimately authorized only the G2 device and one tobacco-flavored pod in March.
Apr.23 by 2FIRSTS.ai
From myblu to Zone: Imperial Brands Refocuses NGP Strategy in HY26
From myblu to Zone: Imperial Brands Refocuses NGP Strategy in HY26
mperial Brands’ HY26 results point to a more selective NGP transition. The company is using cash flow from traditional tobacco to fund targeted investments in modern oral nicotine, heated tobacco and reusable vaping systems. Its decision to exit the legacy myblu vaping business in the U.S., while expanding Zone nicotine pouches. In Europe, Imperial’s NGP growth is being driven by a multi-category portfolio including blu, Pulze and Zone/Skruf.
Special Report
May.12
Australian State Targets Illegal Tobacco Retailers With Tougher Closure Powers
Australian State Targets Illegal Tobacco Retailers With Tougher Closure Powers
According to Reuters, Australia’s state of Victoria introduced legislation to give police and the state tobacco licensing regulator stronger powers to shut businesses selling illegal tobacco, with non-compliant operators facing fines of more than A$2.4 million and up to 20 years in prison.
Jun.05